The booming industry of vitamin supplements is undeniable, with millions of Americans spending a significant amount of money on pills, gummies, and powders in the hopes of improving their health. However, experts argue that most individuals are simply wasting their money. Dr. Matthew Silvis, vice chair of clinical operations for Penn State Health, emphasizes that
0 Comments
A pharmaceutical company in Japan, Kobayashi Pharmaceutical, is currently investigating five deaths that may be linked to dietary supplements designed to lower cholesterol. The company has issued a recall for three brands of over-the-counter tablets after customers reported kidney problems. The supplements in question contain red yeast rice, also known as “beni koji”. Following the
0 Comments
Dr. Gary Gibbon, a 69-year-old pulmonologist-allergist-immunologist from Santa Monica, faced a dire situation when he was diagnosed with advanced lung cancer that had spread to the point of causing irreparable damage to his liver. Despite the grim prognosis, Gibbon refused to give up hope and sought out a cutting-edge solution that would ultimately save his
0 Comments
Prostate cancer is a common issue for older men, with approximately 300,000 new cases in the U.S. each year. However, not all prostate cancers require treatment or even need to be biopsied. A new meta-analysis by investigators from Brigham and Women’s Hospital suggests that combining MRI of the prostate findings with prostate-specific antigen (PSA) density
0 Comments
The study conducted by researchers at the University of Colorado Anschutz Medical Campus sheds light on the prevalence of men with additional X or Y chromosomes in the United States. This comprehensive research, published in JAMA Network Open, has significant implications for the early diagnosis and treatment of conditions associated with these genetic variations. However,
0 Comments
In a groundbreaking study led by Chunmei Cui from Peking University, China, new insights have been revealed regarding the relationship between gender and cancer. The research sheds light on the significant sex-specific variances in copy number alterations (CNA) across various cancer types, emphasizing the need for a more gender-tailored approach in cancer prognosis and treatment.
0 Comments
Recent research conducted at UVA Cancer Center has shown that a second-generation melanoma vaccine has significantly improved long-term survival rates for melanoma patients in comparison to the first-generation vaccine. This new vaccine has proven to be particularly beneficial for male patients, raising important questions about the implications for the development of other cancer vaccines in
0 Comments